Safety of GM-CT-01 With and Without 5-Fluorouracil in Patients With Solid Tumors
This study has been completed.
Sponsor:
Galectin Therapeutics Inc.
Information provided by (Responsible Party):
Galectin Therapeutics Inc.
ClinicalTrials.gov Identifier:
NCT00054977
First received: February 14, 2003
Last updated: March 9, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2006 |
| Primary Completion Date: | April 2005 (Final data collection date for primary outcome measure) |